Salix Settles With Novel Over Generic MoviPrep

Law360, New York (August 30, 2010, 4:35 PM EDT) -- Salix Pharmaceuticals Ltd. and Norgine BV have reached a settlement with Novel Laboratories Inc. that will allow the generics maker to launch its own version of colon-cleansing medicine MoviPrep no later than 2018.

The agreement, which still requires court approval, would resolve a patent infringement suit pending against Somerset, N.J.-based Novel in the U.S. District Court for the District of New Jersey, Salix said Monday in a statement.

Salix and Amsterdam-based Norgine sued the generics maker in May 2008 after it submitted an abbreviated new drug...
To view the full article, register now.